Takeda Pharmaceutical (TAK) EV to EBIT (2017 - 2026)
Takeda Pharmaceutical (TAK) EV to EBIT (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EV to EBIT |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 26.84 |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 15.67 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.13 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -18.42 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 14.55 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 3.62 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 136.96 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.52 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 19.55 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1,742.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 23, 2026 | -18.42 |
| Jul 22, 2026 | -18.46 |
| Jul 21, 2026 | -18.96 |
| Jul 20, 2026 | -18.73 |
| Jul 17, 2026 | -18.87 |
| Jul 16, 2026 | -18.29 |
| Jul 15, 2026 | -17.94 |
| Jul 14, 2026 | -17.89 |
| Jul 13, 2026 | -17.99 |
| Jul 10, 2026 | -18.08 |
| Jul 9, 2026 | -18.15 |
| Jul 8, 2026 | -18.33 |
| Jul 7, 2026 | -18.61 |
| Jul 6, 2026 | -18.52 |
| Jul 2, 2026 | -18.35 |
| Jul 1, 2026 | -17.31 |
| Jun 30, 2026 | -17.40 |
| Jun 29, 2026 | -17.33 |
| Jun 26, 2026 | -17.24 |
| Jun 25, 2026 | -16.90 |